Hostname: page-component-586b7cd67f-t7fkt Total loading time: 0 Render date: 2024-11-23T06:56:12.053Z Has data issue: false hasContentIssue false
  • English
  • Français

Prevalencia del uso de MDMA (éxtasis) y neurotoxicidad

Published online by Cambridge University Press:  12 May 2020

I.H.A Franken
I.H.A Franken*
Affiliation:
Centro Psiquiátrico Parnassia, Centro de Investigación de la Adicción Parnassia, Monsterseweg 83, 2553RJ La Haya, Países Bajos

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Carta Al Director
Information
European Psychiatry (Ed. Española) , Volume 9 , Issue 3 , April 2002 , pp. 202
Copyright
Copyright © European Psychiatric Association 2002

References

Bibliografía

Craske, VStevenson, NHalfin, MFrench, P.The Mixmag drugs survey 2000. Mixmag 2001;Feb:55-62.Google Scholar
Halpern, JHPope, HG. JrHallucinogens on the internet: a vast new source of underground drug information. Am J Psychiatry 2001;158:481-3.CrossRefGoogle ScholarPubMed
Morgan, MJ.Ecstasy (MDMA): a review of its possible persistent psychological effects. Psychopharmacology 2000;152:230-48.Google ScholarPubMed
Vollenweider, EXGamma, ALiechti, MHuber, T.Is a single dose of MDMA harmless? Neuropsychopharmacology 1999;21:598-600.Google ScholarPubMed